FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

32570271000036106: Australian English language reference set (foundation metadata concept)

Status: current, Primitive. Date: 25-Dec 2013. Module: Australian common model component extension

Descriptions:

Id Description Lang Type Status Case? Module
108642501000036114 Australian English en Synonym Active Case sensitive Australian common model component extension
108644301000036110 Australian English language reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian common model component extension
108644311000036112 Australian English language reference set en Synonym Active Case sensitive Australian common model component extension
2171000036114 Australian dialect reference set en Synonym Active Case sensitive Australian common model component extension
3306431000168118 ADRS - Australian dialect reference set en Synonym Active Case sensitive Australian common model component extension

943353 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Australian dialect reference set Is a English true Inferred relationship Some
Members acceptabilityId
umol/mol Acceptable
umol/mol Hb Preferred
umol/mol creat Acceptable
uncoated tablet Preferred
undecenoic acid Preferred
undecenoic acid + chloroxylenol Preferred
undecenoic acid 25% + chloroxylenol 3% solution Preferred
undecenoic acid 25% + chloroxylenol 3% solution, 30 mL Preferred
undecylenamide dea Preferred
unit Preferred
unit dose Preferred
unit dose Preferred
unit of measure Preferred
unit of use Preferred
unit/dL Acceptable
unit/day Acceptable
unit/each Preferred
unit/gm Hb Acceptable
unit/hour Acceptable
unit/kg Acceptable
unit/kg/min Acceptable
unit/litre Acceptable
unit/m2 Acceptable
unit/m3 Acceptable
unit/mL Preferred
unit/mL Acceptable
unit/millilitre Acceptable
unit/week Acceptable
upadacitinib Preferred
upadacitinib Preferred
upadacitinib 15 mg modified release tablet Preferred
upadacitinib 15 mg modified release tablet, 28 Preferred
upadacitinib 15 mg modified release tablet, 7 Preferred
upadacitinib 30 mg modified release tablet Preferred
upadacitinib 30 mg modified release tablet, 28 Preferred
upadacitinib 30 mg modified release tablet, 7 Preferred
upadacitinib 45 mg modified release tablet Preferred
upadacitinib 45 mg modified release tablet, 28 Preferred
upadacitinib 45 mg modified release tablet, 7 Preferred
urea Preferred
urea Preferred
urea (13C) Preferred
urea (13C) Preferred
urea (13C) 50 mg tablet Preferred
urea (13C) 50 mg tablet, 1 Preferred
urea (13C) 50 mg tablet, 10 Preferred
urea (14C) Preferred
urea (14C) Preferred
urea (14C) 37 kBq capsule Preferred
urea (14C) 37 kBq capsule, 1 Preferred
urea (14C) 37 kBq capsule, 10 Preferred
urea (14C) 37 kBq capsule, 100 Preferred
urea + lactic acid Preferred
urea 10% + lactic acid 5% cream Preferred
urea 10% + lactic acid 5% cream, 100 g Preferred
urea 10% cream Preferred
urea 10% cream, 10 g Preferred
urea 10% cream, 100 g Preferred
urea 10% cream, 250 g Preferred
urea 10% cream, 50 g Preferred
urea 10% cream, 500 g Preferred
urea 40% ointment Preferred
urea 40% ointment, 10 g Preferred
urokinase Preferred
urokinase Preferred
urokinase 100 000 units injection, 1 vial Preferred
urokinase 100 000 units injection, vial Preferred
urokinase 500 000 units injection, 1 vial Preferred
urokinase 500 000 units injection, vial Preferred
ursodeoxycholic acid Preferred
ursodeoxycholic acid Preferred
ursodeoxycholic acid 250 mg capsule Preferred
ursodeoxycholic acid 250 mg capsule, 100 Preferred
ursodeoxycholic acid 250 mg capsule, 60 Preferred
ursodeoxycholic acid 50 mg/mL oral liquid Preferred
ursodeoxycholic acid 50 mg/mL oral liquid, 250 mL Preferred
ursodeoxycholic acid 500 mg tablet Preferred
ursodeoxycholic acid 500 mg tablet, 100 Preferred
ursodeoxycholic acid 500 mg tablet, 25 Preferred
ursodeoxycholic acid 500 mg tablet, 50 Preferred
us Preferred
ustekinumab Preferred
ustekinumab Preferred
ustekinumab 130 mg/26 mL injection, 26 mL vial Preferred
ustekinumab 130 mg/26 mL injection, vial Preferred
ustekinumab 45 mg/0.5 mL injection, 0.5 mL syringe Preferred
ustekinumab 45 mg/0.5 mL injection, 0.5 mL vial Preferred
ustekinumab 45 mg/0.5 mL injection, syringe Preferred
ustekinumab 45 mg/0.5 mL injection, vial Preferred
ustekinumab 90 mg/mL injection, 1 mL syringe Preferred
ustekinumab 90 mg/mL injection, 1 mL vial Preferred
ustekinumab 90 mg/mL injection, syringe Preferred
ustekinumab 90 mg/mL injection, vial Preferred
v Preferred
v wave Preferred
v-AT - ataxia telangiectasia variant Acceptable
v-Raf murine sarcoma viral oncogene homolog B1 Acceptable
v/v Preferred
vCJD - variant Creutzfeldt-Jakob disease Acceptable
vWD - Congenital von Willebrand's disease Acceptable
vWD - Congenital von Willebrand's disease type I Acceptable

Start Previous Page 9420 of 9434 Next End

Reference Sets

Reference set descriptor

Back to Start